OXFD News and Press, Oxford Immunotec Global PLC From 11/05/19

The following slide deck was published by Oxford Immunotec Global PLC in conjunction with their 2019 Q3 earnings Read more ...

Oxford Immunotec Global (NASDAQ: OXFD ): Q3 GAAP EPS of $0.04 beats by $0.07 . More news on: Oxford Immunotec Global PLC, Earnings news and commentary, Healthcare stocks news, Read more ...

Third quarter revenue of $21.2 million, an increase of 32% compared to prior year period Gross margin of 73%, an increase of 150 basis points from the prior year period Positive net income of $0.7 million compared to a net loss of ($3.5) million in prior year period OXFORD, Unit...

OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to release third quarter 2019 financial results before the open of the market on ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Oxford Immunotec Global PLC (OXFD) Q2 2019 Results Earnings Conference Call August 6, 2019 08:00 AM ET Company Participants Matt McLaughlin - Chief Financial Officer Peter Wrighton-Smith - Chief Executive Officer, Director Conference Call Participants Rachel Vatnsdal - Pipe...

Second quarter revenue of $19.6 million, an increase of 18% compared to prior year period Gross margin of 72.4%, reflecting our shift towards a pure-play kit business Positive net income of $0.6 million compared to a net loss of $6.5 million in prior year period OXFORD, United K...

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2019 financial results before the open of the market...

Oxford Immunotec Global ( OXFD -1.8% ) has appointed Patrick J. Balthrop, Sr. as Chairman of its board of directors. More news on: Oxford Immunotec Global PLC, Healthcare stocks news, Read more ...